Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
(+)-chlorpheniramine | 918 | 3H-PYRILAMINE | 42 | Human | Binding | pKi | = | 2910.00 | 5.54 | -295 | 27 | - | PDSP KiDatabase | 274.1 | 5 | 0 | 2 | 3.82 | CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1 | - | |
(+)-chlorpheniramine | 918 | None | 42 | Human | Binding | pKi | = | 6.67 | 8.18 | -295 | 27 | None | Drug Central | 274.1 | 5 | 0 | 2 | 3.82 | CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1 | - | |
(-)-stepholidine | 3691 | 3H-Histamine | 40 | Human | Binding | pKi | = | 10000.00 | 5.00 | -2290 | 35 | - | PDSP KiDatabase | 327.1 | 2 | 2 | 5 | 2.77 | COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2 | - | |
(1R,2S)-PHENYLPROPANOLAMINE | 27120 | 3H-Histamine | 13 | Human | Binding | pKi | = | 10000.00 | 5.00 | -38 | 42 | - | PDSP KiDatabase | 151.1 | 2 | 2 | 2 | 1.07 | C[C@H](N)[C@H](O)c1ccccc1 | - | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | pKi | None | - | 6.70 | -208 | 7 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11179434 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | pKi | None | - | 6.70 | -208 | 7 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11561071 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | pKi | None | - | 6.70 | -208 | 7 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11181941 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | pKi | None | - | 6.70 | -208 | 7 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11179436 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | pKd | None | - | 7.20 | -208 | 7 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11179434 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | Ki | = | 146.00 | 6.84 | -208 | 7 | Binding affinity to the human histamine H4 receptor | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.1021/jm0341047 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | EC50 | = | 1122.02 | 5.95 | -208 | 7 | Inhibitory activity determined by the inhibition of cAMP- stimulated beta-galactosidase transcription in SK-N-MC cells expressing the human Histamine H4 receptor | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.1021/jm030905y | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | Ki | = | 184.00 | 6.74 | -208 | 7 | Displacement of [3H]histamine from human histamine H4 receptor expressed in SK-NM-C cells | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.1021/jm7014777 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | Ki | = | 251.19 | 6.60 | -208 | 7 | Displacement of [3H]-histamine from human histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2 | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Binding | Ki | = | 169.00 | 6.77 | -208 | 7 | PDSP Secondary Binding target: HRH4 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity. | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.6019/CHEMBL5442175 | |
(R)-α-methylhistamine | 2067 | None | 16 | Mouse | Binding | pKi | None | - | 6.40 | -537 | 7 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11561071 | |
(R)-α-methylhistamine | 2067 | None | 16 | Rat | Binding | pKi | None | - | 6.20 | -851 | 7 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11561071 | |
(S)-α-methylhistamine | 2082 | None | 7 | Human | Binding | Ki | = | 3981.07 | 5.40 | -35 | 3 | Displacement of [3H]-histamine from human histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2 | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
(S)-α-methylhistamine | 2082 | None | 7 | Human | Binding | pKi | None | - | 5.50 | -35 | 3 | Unclassified | Guide to Pharmacology | 125.1 | 2 | 2 | 2 | 0.30 | C[C@H](N)Cc1cnc[nH]1 | https://pubmed.ncbi.nlm.nih.gov/11181941 | |
2-(3-bromophenyl)histamine | 45 | None | 1 | Human | Binding | pKi | None | - | 6.00 | -1318 | 4 | Unclassified | Guide to Pharmacology | 265.0 | 3 | 2 | 2 | 2.34 | NCCc1cnc(-c2cccc(Br)c2)[nH]1 | https://pubmed.ncbi.nlm.nih.gov/15947036 | |
2-(3-bromophenyl)histamine | 45 | None | 1 | Human | Binding | Ki | = | 1584.89 | 5.80 | -1318 | 4 | Displacement of [3H]-histamine from human histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2 | ChEMBL | 265.0 | 3 | 2 | 2 | 2.34 | NCCc1cnc(-c2cccc(Br)c2)[nH]1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 |
Showing 1 to 20 of 2,245 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
(R)-α-methylhistamine | 2067 | None | 16 | Human | Functional | EC50 | = | 630.96 | 6.20 | -549 | 7 | Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
(S)-α-methylhistamine | 2082 | None | 7 | Human | Functional | EC50 | = | 12589.25 | 4.90 | -1258 | 3 | Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.30 | C[C@H](N)Cc1cnc[nH]1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
2-(3-bromophenyl)histamine | 45 | None | 1 | Human | Functional | EC50 | = | 10000.00 | 5.00 | -50 | 4 | Agonist activity at human recombinant histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2 by steady-state GTPase activity assay | ChEMBL | 265.0 | 3 | 2 | 2 | 2.34 | NCCc1cnc(-c2cccc(Br)c2)[nH]1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
2-METHYLHISTAMINE | 17994 | None | 20 | Human | Functional | EC50 | = | 3981.07 | 5.40 | -5 | 2 | Agonist activity at human recombinant histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2 by steady-state GTPase activity assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1ncc(CCN)[nH]1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
4-methylhistamine | 121 | None | 34 | Human | Functional | EC50 | = | 39.81 | 7.40 | 35 | 7 | Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
4-methylhistamine | 121 | None | 34 | Human | Functional | EC50 | = | 31.62 | 7.50 | 35 | 7 | Agonist activity at human recombinant histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2 by steady-state GTPase activity assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
4-methylhistamine | 121 | None | 34 | Human | Functional | EC50 | = | 70.79 | 7.15 | 35 | 7 | Agonist activity at human histamine H4 receptor expressed in Sf9 cells coexpressing RGS19 protein by steady-state GTPase assay | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1021/jm900526h | |
4-methylhistamine | 121 | None | 34 | Mouse | Functional | EC50 | = | 1584.89 | 5.80 | -35 | 7 | Agonist activity at mouse histamine H4 receptor | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
4-methylhistamine | 121 | None | 34 | Rat | Functional | EC50 | = | 2511.89 | 5.60 | -56 | 7 | Agonist activity at rat histamine H4 receptor | ChEMBL | 125.1 | 2 | 2 | 2 | 0.22 | Cc1[nH]cnc1CCN | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
adriforant | 295 | None | 13 | Human | Functional | IC50 | = | 53.70 | 7.27 | - | 5 | Antagonist activity at human histamine H4 receptor expressed in HEK cells assessed as inhibition of histamine-induced [35S]GTPgammaS binding | ChEMBL | 262.2 | 5 | 3 | 6 | 0.68 | CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1 | https://dx.doi.org/10.1016/j.bmcl.2013.02.091 | |
adriforant | 295 | None | 13 | Human | Functional | IC50 | = | 1.30 | 8.89 | - | 5 | Antagonist activity at H4R in human eosinophils assessed as inhibition of histamine-induced actin polymerisation | ChEMBL | 262.2 | 5 | 3 | 6 | 0.68 | CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1 | https://dx.doi.org/10.1016/j.bmcl.2011.07.125 | |
adriforant | 295 | None | 13 | Human | Functional | IC50 | = | 4.90 | 8.31 | - | 5 | Antagonist activity at H4R in human eosinophils assessed as inhibition of histamine-induced CD11b upregulation | ChEMBL | 262.2 | 5 | 3 | 6 | 0.68 | CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1 | https://dx.doi.org/10.1016/j.bmcl.2011.07.125 | |
adriforant | 295 | None | 13 | Human | Functional | IC50 | = | 0.65 | 9.19 | - | 5 | Antagonist activity at H4R in human eosinophils assessed as inhibition of histamine-induced shape change by GAFS assay | ChEMBL | 262.2 | 5 | 3 | 6 | 0.68 | CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1 | https://dx.doi.org/10.1016/j.bmcl.2011.07.125 | |
adriforant | 295 | None | 13 | Human | Functional | Ki | = | 1.56 | 8.81 | - | 5 | Antagonist activity at full length human H4R expressed in HEK293 cells assessed as reversal of forskolin-induced cAMP production by CRE-beta-lactamase reporter gene assay | ChEMBL | 262.2 | 5 | 3 | 6 | 0.68 | CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1 | https://dx.doi.org/10.1016/j.bmcl.2011.07.125 | |
BURIMAMIDE | 15502 | None | 19 | Human | Functional | EC50 | = | 19.95 | 7.70 | - | 7 | Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay | ChEMBL | 212.1 | 5 | 3 | 2 | 1.24 | C/N=C(\S)NCCCCc1c[nH]cn1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
CCL16 | 831 | None | 0 | Human | Functional | pIC50 | None | - | 8.10 | - | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/15265943 | |
CHEMBL105803 | 5152 | None | 0 | Human | Functional | EC50 | = | 741.31 | 6.13 | -7 | 2 | Inhibition of the forskolin-stimulated cAMP production in SK-N-MC cells expressing human Histamine H4 receptor | ChEMBL | 258.1 | 5 | 1 | 3 | 2.85 | c1ccc(COC[C@H]2CC[C@H](c3c[nH]cn3)O2)cc1 | https://dx.doi.org/10.1021/jm0300025 | |
CHEMBL105803 | 5152 | None | 0 | Human | Functional | EC50 | = | 794.33 | 6.10 | -7 | 2 | Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay | ChEMBL | 258.1 | 5 | 1 | 3 | 2.85 | c1ccc(COC[C@H]2CC[C@H](c3c[nH]cn3)O2)cc1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 | |
CHEMBL106158 | 5211 | None | 0 | Human | Functional | EC50 | = | 223.87 | 6.65 | 47 | 2 | Inhibition of the forskolin-stimulated cAMP production in SK-N-MC cells expressing human Histamine H4 receptor | ChEMBL | 248.1 | 3 | 3 | 4 | 0.28 | C/N=C(\NC#N)NC[C@@H]1CC[C@H](c2c[nH]cn2)O1 | https://dx.doi.org/10.1021/jm0300025 | |
CHEMBL106158 | 5211 | None | 0 | Human | Functional | EC50 | = | 199.53 | 6.70 | 47 | 2 | Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay | ChEMBL | 248.1 | 3 | 3 | 4 | 0.28 | C/N=C(\NC#N)NC[C@@H]1CC[C@H](c2c[nH]cn2)O1 | https://dx.doi.org/10.1016/j.bmcl.2010.10.041 |
Showing 1 to 20 of 572 entries